Iccofen (Diclofenac Diethylamine)

Diclofenac diethylamine penetrates the skin and blocks the cyclooxygenase enzymes COX‑1 and COX‑2, which reduces the production of prostaglandins. Lower prostaglandin levels diminish inflammation and pain at the site where the product is applied.

The appropriate amount and frequency of Iccofen are determined by the prescribing healthcare professional based on the severity of the condition, the area of application, and individual patient factors. Patients should follow the prescriber’s instructions and the product label.

Diclofenac-containing topical products are generally avoided in the third trimester of pregnancy because of potential fetal risks. Safety during early pregnancy and lactation has not been fully established, so a healthcare provider should be consulted before use.

To request Iccofen, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Iccofen contains diclofenac diethylamine, a potent NSAID that offers strong local anti‑inflammatory activity. Compared with other topical NSAIDs such as ibuprofen or ketoprofen gels, diclofenac often provides faster pain relief and is widely studied for musculoskeletal conditions, though individual response may vary.

Store Iccofen at room temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture, excessive heat, and direct sunlight to maintain stability and efficacy.

Iccofen is applied topically to clean, dry skin over the affected area. A thin layer is spread gently and rubbed in until absorbed, usually 2‑4 times daily, or as directed by the prescriber. Hands should be washed after application unless they are the treatment site.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, toxic epidermal necrolysis, and systemic effects like gastrointestinal ulceration, renal impairment, or hepatic dysfunction, especially with extensive or prolonged use.

Individuals with a known hypersensitivity to diclofenac, other NSAIDs, or any component of the formulation should avoid Iccofen. It is also contraindicated on broken or infected skin, in the third trimester of pregnancy, and in patients with severe renal, hepatic, or cardiovascular disease without medical supervision.